5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB
Main Authors: | J. Kanter, K. Ataga, N. Bhasin, S. Guarino, A. Kutlar, S. Lanzkron, D. Manwani, P. McGann, S. Stowell, V. Tubman, I. Yermilov, C. Campos, M.S. Broder |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000928196.80128.ee |
Similar Items
-
S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CELL DISEASE (SCD)
by: J Kanter, et al.
Published: (2022-01-01) -
PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS
by: Miguel Abboud, et al.
Published: (2023-08-01) -
Equivalence Analysis of LCOE and IRR for New Energy Projects
by: Dongjie WANG, et al.
Published: (2023-03-01) -
PI-01: GRNDAD AND COUSIN: INVESTIGATOR-INITIATED COLLABORATIONS TO IMPROVE CARE IN SICKLE CELL DISEASE
by: LITTLE J., et al.
Published: (2022-08-01) -
Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria
by: David Dingli, et al.
Published: (2024-12-01)